Expression analysis of 6p22 genomic gain in retinoblastoma

Genes Chromosomes and Cancer

Volumn 45, Issue 1, 2006, Pages 72-82

  Orlic, Marija ^a,b,c   Spencer, Clarellen E ^b   Wang, Lisa ^b   Gallie, Brenda L ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; BLADDER CANCER; CHROMOSOME 6P; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENOME ANALYSIS; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LEUKEMIA; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RETINOBLASTOMA; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ADULT; ANIMAL; BIOSYNTHESIS; CHROMOSOME 6; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; RETINA; RETINA TUMOR; TRANSGENIC MOUSE; TUMOR CELL LINE;

DEK PROTEIN, HUMAN; E2F3 PROTEIN, HUMAN; E2F3 PROTEIN, MOUSE; KIF13A PROTEIN, HUMAN; KINESIN; MESSENGER RNA; NONHISTONE PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR E2F3;

ADULT; ANIMALS; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOMES, HUMAN, PAIR 6; E2F3 TRANSCRIPTION FACTOR; GENE DOSAGE; GENE EXPRESSION PROFILING; HUMANS; KINESIN; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS; RETINA; RETINAL NEOPLASMS; RETINOBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33644881673     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20263     Document Type: Article

References (33)

1. Adams MR, Sears R, Nuckolls F, Leone G, Nevins JR. 2000. Complex transcriptional regulatory mechanisms control expression of the E2F3 locus. Mol Cell Biol 20:3633-3639.
2. Alexiadis V, Waldmann T, Andersen J, Mann M, Knippers R, Gruss C. 2000. The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. Genes Dev 14:1308-1312.
3. Campillos M, Garcia MA, Valdivieso F, Vazquez J. 2003. Transcriptional activation by AP-2α is modulated by the oncogene DEK. Nucleic Acids Res 31:1571-1575.
4. Cano J, Oliveros O, Yunis E. 1994. Phenotype variants, malignancy, and additional copies of 6p in rerinoblastoma. Cancel Genet Cytogenet 76:112-115.
5. Chen D, Gallie BL, Squire JA. 2001. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 129:57-63.
6. Chen D, Pajovic S, Duckett A, Brown VD, Squire JA, Gallie BL. 2002. Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN. Cancer Res 62:967-971.
7. Cooper GM. 1995. Oncogenes, 2nd ed. Sudbury, MA: Jones and Bartlett. p. 384.
8. Devany M, Kotharu NP, Matsuo H. 2004. Solution NMR structure of the C-terminal domain of the human protein DEK. Protein Sci 13:2252-2259.
9. Evans AJ, Gallie BL, Jewett MA, Pond GR, Vandezande K, Underwood J, Fradet Y, Lim G, Marrano P, Zielenska M, Squire JA. 2004. Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction. Am J Pathol 164:285-293.
10. Feber A, Clark J, Goodwin G, Dodson AR, Smith PH, Fletcher A, Edwards S, Flohr P, Falconer A, Roe T, Kovacs G, Dennis N, Fisher C, Wooster R, Huddart R, Foster CS, Cooper CS. 2004. Amplification and overexpression of E2F3 in human bladder cancer. Oncogene 23:1627-1630.
11. Foster CS, Falconer A, Dodson AR, Norman AR, Dennis N, Fletcher A, Southgate C, Dowe A, Dearnaley D, Jhavar S, Eeles R, Feber A, Cooper CS. 2004. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene 23:5871-5879.
12. Gallie BL, Campbell C, Devlin H, Duckett A, Squire JA. 1999. Developmenral basis of retinal-specific induction of cancer by RB mutation. Cancer Res 59:1731s-1735s.
13. Grottke C, Mantwill K, Dietel M, Schadendorf D, Lage H. 2000. Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs. Int J Cancer 88:535-546.
14. Herzog S, Lohmann DR, Buiting K, Schuler A, Horsthemke B, Rehder H, Rieder H. 2001. Marked differences in unilateral isolated retinoblastomas from young and older children studied by compararive genomic hybridization. Hum Genet 108:98-104.
15. Kappes F, Burger K, Baack M, Fackelmayer FO, Gruss C. 2001. Subcellular localization of the human proto-oncogene protein DEK. J Biol Chem 276:26317-26323.
16. Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M, Tanaka K, Shuda M, Yamamoto M. 1999. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 59:4990-4996.
17. Kroes RA, Jastrow A, McLone MG, Yamamoto H, Colley P, Kersey DS, Yong VW, Mkrdichian E, Cerullo L, Leestma J, Moskal JR. 2000. The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Lett 156:191-198.
18. Larramendy ML, Niini T, Elonen E, Nagy B, Ollila J, Vihinen M, Knuutila S. 2002. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis. Haematologica 87:569-577.
19. Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, Miron A, Nevins JR. 2000. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol Cell Biol 20:3626-3632.
20. Lillington DM, Kingston JE, Coen PG, Price E, Hungerford J, Domizio P, Young BD, Onadim Z. 2003. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosomes Cancer 36:121-128.
21. Mairal A, Pinglier E, Gilbert E, Peter M, Validire P, Desjardins L, Doz F, Aurias A, Couturier J. 2000. Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosomes Cancer 28:370-379.
22. Marchong MN, Chen D, Corson TW, Lee C, Harmandayan M, Bowles E, Chen N, Gallie BL. 2004. Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. Mol Cancer Res 2:495-503.
23. McGarvey T, Rosonina E, McCracken S, Li Q, Arnaout R, Mientjes E, Nickerson JA, Awrey D, Greenblatt J, Grosveld G, Blencowe BJ. 2000. The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes. J Cell Biol 150:309-320.
24. Oeggerli M, Tomovska S, Schraml P, Calvano-Forte D, Schafroth S, Simon R, Gasser T, Mihatsch MJ, Sauter G. 2004. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene 23:5616-5623.
25. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM. Chittenden T. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157-166.
26. Squire J, Gallie BL, Phillips RA. 1985. A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet 70:291-301.
27. Squire J, Phillips RA, Boyce S, Godbout R, Rogers B, Gallie BL. 1984. Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: verification by standard staining techniques, new densitometric methods, and somatic cell hybridization. Hum Genet 66:46-53.
28. von Lindern M, Fornerod M, Soekarman N, van Baal S, Jaegle M, Hagemeijer A, Bootsma D, Grosveld G. 1992. Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene. Baillieres Clin Haematol 5:857-879.
29. Waldmann T, Baack M, Richter N, Gruss C. 2003. Structure-specific binding of the proto-oncogene protein DEK to DNA. Nucleic Acids Res 31:7003-7010.
30. Waldmann T, Eckerich C, Baack M, Gruss C. 2002. The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils. J Biol Chem 277:24988-24994.
31. Windle JJ, Albert DM, O'Brien JM, Marcus DM, Disteche CM, Bernards R, Mellon PL. 1990. Retinoblastoma in transgenic mice. Nature 343:665-669.
32. Wu Q, Hoffmann MJ, Hartmann FH, Schulz WA. 2005. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer. Mol Cancer 4:16.
33. Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radlwimmer B, Lohmann DR, Lichter P. 2005. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer 43:294-301.